A see-through zebrafish and enhanced imaging provide the first direct glimpse of how blood stem cells take root in the body to generate blood.
Reporting online in Cell on Jan. 15, researchers describe a surprisingly dynamic system that offers several clues for improving bone marrow transplants in patients with cancer, severe immune deficiencies and blood disorders, and for helping those transplants “take.”
The steps are detailed in an animation narrated by senior investigator Leonard Zon, professor of stem cell and regenerative biology in the Faculty of Arts and Sciences at Harvard University. (A more technical version of the animation is also available.)
“The same process occurs during a bone marrow transplant as occurs in the body naturally,” said Zon, who is also the Grousbeck Professor of Pediatrics at Boston Children’s Hospital and director of the Boston Children’s Stem Cell Research Program. “Our direct visualization gives us a series of steps to target, and in theory we can look for drugs that affect every step of that process.”
“Stem cell and bone marrow transplants are still very much a black box—cells are introduced into a patient and later on we can measure recovery of their blood system, but what happens in between can’t be seen,” said Owen Tamplin, HMS research fellow in pediatrics at Boston Children’s and the paper’s co-first author. “Now we have a system where we can actually watch that middle step.”
The blood system’s origins
It had already been known that blood stem cells bud off from cells in the aorta, then circulate in the body until they find a niche where they’re prepped for their future job making blood for the body.
Now, for the first time, researchers have revealed how this niche forms, using time-lapse imaging of naturally transparent zebrafish embryos and a genetic trick that tagged the stem cells green.
On arrival in its niche, which in the zebrafish is in the tail, the newborn blood stem cell attaches itself to the blood vessel wall. There, chemical signals prompt it to squeeze itself through the wall and into a space just outside the blood vessel.
“In that space, a lot of cells begin to interact with it,” said Zon. Nearby endothelial (blood vessel) cells wrap themselves around it. “We think that is the beginning of making a stem cell happy in its niche, like a mother cuddling a baby.”
As the stem cell is being cuddled, it’s brought into contact with a nearby stromal or “nurse” cell that helps keep it attached. The stem cell hooks onto the nurse cell tightly, in a process Zon likens to early attachment of an infant to its mother.
The cuddling was reconstructed from confocal and electron microscopy images of the zebrafish taken during this stage. Through a series of image slices, the researchers were able to reassemble the whole 3-D structure—stem cell, cuddling endothelial cells and stromal cells.
“Nobody’s ever visualized live how a stem cell interacts with its niche,” said Zon. “This is the first time we get a very high-resolution view of the process.”
Eventually, the cuddled stem cell begins dividing. One daughter cell leaves the niche while the other stays. Eventually, all the stem cells leave and begin colonizing their future site of blood production. In fish, this is in the kidney.
Further imaging done in mice found evidence that blood stem cells go through much the same process in mammals, which makes it likely in humans too. In humans, blood stem cells set up permanent residence in the bone marrow.
These detailed observations are already informing the Zon lab’s attempt to improve bone marrow transplantation. By doing a chemical screen in large numbers of zebrafish embryos, the researchers found that the compound lycorine promotes interaction between the blood stem cell and its niche, leading to greater numbers of blood stem cells in the adult fish.
Ellen Durand in the Zon lab was co-first author on the study. Additional authors were Logan Carr, Elliott Hagedorn and Pulin Lee of Boston Children’s; Sarah Childs of the University of Calgary; and Amanda Yzaguirre and Nancy Speck of the University of Pennsylvania.
The study was funded by the Howard Hughes Medical Institute, the National Institutes of Health (grants R01 HL04880, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, R24 DK092760 and R01 HL091724), the American Society of Hematology, the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.
Stay informed via email on the latest news, research, and
media from Harvard Medical School.